✦ LIBER ✦

Cost-effectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-infected patients

✍ Scribed by Rainel Sánchez-de la Rosa; Luis Herrera; Santiago Moreno

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN43 Cost Effectiveness Analysis of the

✍ Soto molina, H.; Pizarro, M.; Vargas, G.; Rizzoli, A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Incidence of renal toxicity in HIV-infec

✍ Calza, Leonardo; Trapani, Filippo; Salvadori, Caterina; Magistrelli, Eleonora; M 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 106 KB

Budget impact of a set-dose combination

✍ Itziar Oyagüez; Miguel A. Casado; Manuel Cotarelo; Antonio Ramírez-Arellano; Jos 📂 Article 📅 2009 🏛 Elsevier ⚖ 269 KB

PIN30 COST EFFECTIVENESS ANALYSIS OF THE

✍ A. Rizzoli-Cordoba; I. Delgado-Ginebra; M. Pizarro-Castellanos; J.J. Castillo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

A randomized study of combined zidovudin

✍ Ross E. McKinney Jr.; George M. Johnson; Kenneth Stanley; Florence H. Yong; Amy 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Safety and efficacy of Tenofovir/Emtrici

✍ Pammi, M.; Arumainayagam, J.; Kumari, B.; Ahmed-Jushuf, I.; Carlin, E. M; Chandr 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB